The case for peripheral CB₁ receptor blockade in the treatment of visceral obesity and its cardiometabolic complications. 28 May Continue reading →
Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. 28 May Continue reading →